"Tele-riabilitazione in Sclerosi Multipla: continuità Terapeutica Domiciliare Dopo Trattamento di Neuro-riabilitazione Intensiva, Studio Randomizzato Controllato Con Piattaforma Integrata Per la Riabilitazione Del Disequilibrio"

Running, not recruitingNot a drug-phase studyMS (type not specified)NCT06699095

What it found

Still running

No result yet.

What was tested

Treatment tested

  • Telerehabilitation

What it measured

Main measures

  • Feasibility

    Home rehabilitation, from the end of the intensive treatment to the follow up evaluation (12 weeks)

    SafetyFeasibility

Other measures (9)

  • Telehealthcare Satisfaction Questionnaire (TSQ)

    From the end of the intensive treatment to the follow up evaluation (12 weeks)

    Quality of life (reported by participants)
  • Telehealthcare Usability Questionnaire (TUQ)

    From the end of the intensive treatment to the follow up evaluation (12 weeks)

    Quality of life (reported by participants)
  • Timed Up and Go test (TUG)

    From the end of the intensive treatment to the follow up evaluation (12 weeks)

    Walking and mobility
  • Timed 10-Meter Walk Test

    From the end of the intensive treatment to the follow up evaluation (12 weeks)

    Walking and mobility
  • Equiscale test

    From the end of the intensive treatment to the follow up evaluation (12 weeks)

    Walking and mobility
  • 12-Item Multiple Sclerosis Walking Scale

    From the end of the intensive treatment to the follow up evaluation (12 weeks)

    Walking and mobility
  • Multiple Sclerosis Quality of Life Questionnaire-54 (MSQoL-54)

    From the end of the intensive treatment to the follow up evaluation (12 weeks)

    Thinking and memoryBladder, bowel and sexual functionPainQuality of life (reported by participants)
  • Modified Fatigue Impact Scale (M-FIS)

    From the end of the intensive treatment to the follow up evaluation (12 weeks)

    Thinking and memoryFatigue
  • Patient Health Engagement scale (PHE scale)

    From the end of the intensive treatment to the follow up evaluation (12 weeks)

Who could take part

MS (type not specified) · 18 to 65

Show the full criteria

Inclusion criteria

* Expanded Disability Status Scale score between 3 and 6 * Sensory Organisation Test Equitest values indicating balance impairment

Exclusion criteria

* visual impairments * orthopedic impairments * inability to perform balance rehabilitation in stand up position

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

RCT pilot study to evaluate adherence, satisfaction and feasibility in the use of a telemedicine station for balance rehabilitation in patients with multiple sclerosis. The platform is designed as a tool for maintenance rehabilitation in a home setting and not as an alternative to intensive treatment in hospital, and is therefore compared to maintenance treatment as usual (TAU) after intensive treatment.

Papers

Loading reviews and guidelines…

History

    1. Started

      Nov 2024

    2. Main results due

      Nov 2025

    3. Finished

      Nov 2026

    Assembled by software from public sources.